Peptide‐based imaging agents for cancer detection
暂无分享,去创建一个
Xiaolian Sun | Xiaoyuan Chen | Yesen Li | Xianzhong Zhang | Xiaoyuan Chen | Xianzhong Zhang | Xiaolian Sun | Yesen Li | Ting Liu | Zijing Li | Zijing Li | Ting Liu
[1] J. Blum,et al. A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules. , 2000, Chest.
[2] Shimon Weiss,et al. Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. , 2004, Journal of the American Chemical Society.
[3] R. Jensen,et al. Bombesin receptor-mediated imaging and cytotoxicity: review and current status. , 2011, Current drug delivery.
[4] M. Pierschbacher,et al. Concept and progress in the development of RGD‐containing peptide pharmaceuticals , 1995, Biopolymers.
[5] E Ruoslahti,et al. RGD and other recognition sequences for integrins. , 1996, Annual review of cell and developmental biology.
[6] P. Verhaert,et al. The emergence of peptides in the pharmaceutical business: From exploration to exploitation , 2014 .
[7] M. Tweedle. Peptide-targeted diagnostics and radiotherapeutics. , 2009, Accounts of chemical research.
[8] Martin Gotthardt,et al. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] Quanzheng Li,et al. Dynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe , 2012, Theranostics.
[10] K. Sodhi,et al. 68Ga-DOTATATE positron emission tomography/computed tomography scan in the detection of bone metastases in pediatric neuroendocrine tumors , 2014, Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India.
[11] Xiang-yi Ma,et al. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT. , 2015, Nuclear medicine and biology.
[12] S. Mather,et al. Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes , 2006, Nature Protocols.
[13] A. Hubalewska-Dydejczyk,et al. GLP-1 and exendin-4 for imaging endocrine pancreas. A review. Labelled glucagon-like peptide-1 analogues: past, present and future. , 2015, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[14] A. Epenetos,et al. Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide , 1998, European Journal of Nuclear Medicine.
[15] S. Gambhir,et al. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] C. Van de Wiele,et al. Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals. , 2008, Current pharmaceutical design.
[17] R. Baum,et al. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[18] Xiaoyuan Chen,et al. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer. , 2009, Bioconjugate chemistry.
[19] S. Gambhir,et al. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.
[20] Xiaoyuan Chen,et al. Pilot Prospective Evaluation of 18F-Alfatide II for Detection of Skeletal Metastases , 2015, Theranostics.
[21] J. Pablo,et al. Thermodynamic Stability of β-Peptide Helices and the Role of Cyclic Residues , 2006 .
[22] Sanjiv S Gambhir,et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. , 2006, Nano letters.
[23] Seulki Lee,et al. Peptides and peptide hormones for molecular imaging and disease diagnosis. , 2010, Chemical reviews.
[24] T. Siahaan,et al. The effect of conformation on the solution stability of linear vs. cyclic RGD peptides. , 1999, The journal of peptide research : official journal of the American Peptide Society.
[25] H. Maecke. Radiolabeled peptides in nuclear oncology: influence of peptide structure and labeling strategy on pharmacology. , 2005, Ernst Schering Research Foundation workshop.
[26] Mithat Gönen,et al. Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe , 2014, Science Translational Medicine.
[27] Judit Erchegyi,et al. Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors , 2006, Proceedings of the National Academy of Sciences.
[28] S. Deutscher. Phage display in molecular imaging and diagnosis of cancer. , 2010, Chemical reviews.
[29] D. Pan,et al. Imaging Integrin αvβ3 and NRP-1 Positive Gliomas with a Novel Fluorine-18 Labeled RGD-ATWLPPR Heterodimeric Peptide Probe , 2014, Molecular Imaging and Biology.
[30] R. Chen,et al. TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis , 2008, Clinical Cancer Research.
[31] P. Conti,et al. RGD-based PET tracers for imaging receptor integrin αv β3 expression. , 2013, Journal of labelled compounds & radiopharmaceuticals.
[32] Otto C. Boerman,et al. Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors , 2010, Amino Acids.
[33] K. Tatemoto,et al. Neuropeptide Y: History and Overview , 2004 .
[34] M. Reiser,et al. Comparison of abdominal MRI with diffusion-weighted imaging to 68Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreas , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[35] P. Workman,et al. Discovery of small molecule cancer drugs: Successes, challenges and opportunities , 2012, Molecular oncology.
[36] Sanjiv S Gambhir,et al. A molecular imaging primer: modalities, imaging agents, and applications. , 2012, Physiological reviews.
[37] Stephen D. A. Hupp,et al. History and Overview , 2010 .
[38] Zhongchan Sun,et al. Comparison of Three Dimeric 18F-AlF-NOTA-RGD Tracers , 2014, Molecular Imaging and Biology.
[39] S. Gambhir,et al. microPET Imaging of Glioma Integrin αvβ3 Expression Using 64Cu-Labeled Tetrameric RGD Peptide , 2005 .
[40] H. Wester,et al. Molecular imaging targeting peptide receptors. , 2009, Methods.
[41] S. Schulz,et al. Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] U. Knigge,et al. PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature. , 2014, Future oncology.
[43] Q. Xie,et al. First Experience of 18F-Alfatide in Lung Cancer Patients Using a New Lyophilized Kit for Rapid Radiofluorination , 2013, The Journal of Nuclear Medicine.
[44] Filip Bergquist,et al. The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors , 2012, The Journal of Neuroscience.
[45] William J. Dower,et al. Toward cell–targeting gene therapy vectors: Selection of cell–binding peptides from random peptide–presenting phage libraries , 1996, Nature Medicine.
[46] J Engel,et al. Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins. , 1994, The Journal of biological chemistry.
[47] H. Kessler,et al. Ligands for mapping alphavbeta3-integrin expression in vivo. , 2009, Accounts of chemical research.
[48] Chor Yong Tay,et al. Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood. , 2015, Chemical Society reviews.
[49] Seulki Lee,et al. Peptide-based probes for targeted molecular imaging. , 2010, Biochemistry.
[50] E. Richelson,et al. Neurotensin: peptide for the next millennium , 2000, Regulatory Peptides.
[51] Yanglong Hou,et al. Multifunctional Nanoparticles for Multimodal Molecular Imaging , 2011 .
[52] Anastasia Nikolopoulou,et al. Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting , 2008, Journal of Nuclear Medicine.
[53] Xiaoyuan Chen,et al. Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding , 2016, Theranostics.
[54] Xiaoyuan Chen,et al. Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy. , 2016, Chemical Society reviews.
[55] J. Reubi,et al. Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide Treatment , 2011, The Journal of Nuclear Medicine.
[56] R Weissleder,et al. Molecular imaging. , 2009, Radiology.
[57] D. Grainger,et al. Imaging Surface Immobilization Chemistry: Correlation with Cell Patterning on Non‐Adhesive Hydrogel Thin Films , 2008, Advanced functional materials.
[58] A. Mojtahedi,et al. The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature. , 2014, American journal of nuclear medicine and molecular imaging.
[59] Z. Win,et al. The possible role of 68Ga-DOTATATE PET in malignant abdominal paraganglioma , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[60] J. Heath,et al. Design and Optimization of Coin-Shaped Microreactor Chips for PET Radiopharmaceutical Synthesis , 2010, Journal of Nuclear Medicine.
[61] Marion de Jong,et al. Tumor Imaging and Therapy Using Radiolabeled Somatostatin Analogues , 2009 .
[62] David J. Robertson,et al. Nanoparticles and phage display selected peptides for imaging and therapy of cancer. , 2013, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[63] Fan Wang,et al. 68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[64] G. Byk,et al. Backbone cyclization: A new method for conferring conformational constraint on peptides , 1991, Biopolymers.
[65] W Cai,et al. Molecular imaging with nucleic acid aptamers. , 2011, Current medicinal chemistry.
[66] Sanjiv S. Gambhir,et al. Near-Infrared Fluorescent RGD Peptides for Optical Imaging of Integrin αvβ3 Expression in Living Mice , 2005 .
[67] L. Gentilucci,et al. Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. , 2010, Current pharmaceutical design.
[68] R. Gillies,et al. Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors. , 2008, Angewandte Chemie.
[69] N. Erathodiyil,et al. Functionalization of inorganic nanoparticles for bioimaging applications. , 2011, Accounts of chemical research.
[70] Young-Seung Kim,et al. Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers. , 2009, Bioconjugate chemistry.
[71] Wei Chen,et al. Chemical probes for molecular imaging and detection of hydrogen sulfide and reactive sulfur species in biological systems. , 2015, Chemical Society reviews.
[72] Xiaoyuan Chen,et al. Design and development of molecular imaging probes. , 2010, Current topics in medicinal chemistry.
[73] B. Tang,et al. Vasoactive intestinal peptide receptor-based imaging and treatment of tumors (Review). , 2014, International journal of oncology.
[74] R. Jensen,et al. Development of Simplified Vasoactive Intestinal Peptide Analogs with Receptor Selectivity and Stability for Human Vasoactive Intestinal Peptide/Pituitary Adenylate Cyclase-Activating Polypeptide Receptors , 2005, Journal of Pharmacology and Experimental Therapeutics.
[75] Raffaele Pezzilli,et al. Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors , 2010, Journal of Nuclear Medicine.
[76] Shuming Nie,et al. Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging. , 2006, Nanomedicine.
[77] Young Keun Kim,et al. A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. , 2011, Nature nanotechnology.
[78] Bing Wang,et al. Metabolism of nanomaterials in vivo: blood circulation and organ clearance. , 2013, Accounts of chemical research.
[79] Yubin Miao,et al. Alpha-melanocyte stimulating hormone peptide-targeted melanoma imaging. , 2007, Frontiers in bioscience : a journal and virtual library.
[80] X. Zhang,et al. Targeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analogues. , 2010, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.
[81] C. Soto,et al. Converting a peptide into a drug: strategies to improve stability and bioavailability. , 2002, Current medicinal chemistry.
[82] G. Loudos,et al. [99mTc]Demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[83] H. Kessler,et al. Radiolabelled RGD peptides for imaging and therapy , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[84] R. Bale,et al. 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT , 2007, Journal of Nuclear Medicine.
[85] H. Ohki‐Hamazaki,et al. Development and function of bombesin-like peptides and their receptors. , 2005, The International journal of developmental biology.
[86] M. Galanski,et al. Neuroendocrine tumour of the mediastinum: fusion of 18F-FDG and 68Ga-DOTATOC PET/CT datasets demonstrates different degrees of differentiation , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[87] Horst Kessler,et al. Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGD , 2005, PLoS medicine.
[88] Kyung-Han Lee,et al. Hybrid PET/optical imaging of integrin αVβ3 receptor expression using a 64Cu-labeled streptavidin/biotin-based dimeric RGD peptide , 2015, EJNMMI Research.
[89] R. B. Merrifield,et al. Solid-phase peptide synthesis. , 2006, Advances in enzymology and related areas of molecular biology.
[90] Igor L. Medintz,et al. Peptides for specifically targeting nanoparticles to cellular organelles: quo vadis? , 2015, Accounts of chemical research.
[91] Robert K Prud'homme,et al. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy , 2009, Expert opinion on drug delivery.
[92] H. Maecke,et al. Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer , 2012, Theranostics.
[93] Brian G Trewyn,et al. Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems. , 2007, Nanomedicine.
[94] B. Keil,et al. Exendin-4–Based Radiopharmaceuticals for Glucagonlike Peptide-1 Receptor PET/CT and SPECT/CT , 2010, Journal of Nuclear Medicine.
[95] Hirokazu Tamamura,et al. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. , 2005, Blood.
[96] Fan Wang,et al. Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FB-PEG3-Glu-RGD-BBN. , 2009, Journal of medicinal chemistry.
[97] L. Iversen. Neuropeptides: Regulators of Physiological Processes by Fleur L. Strand, MIT Press, 1999. £45.00, $65.00 (xi + 658 pages) ISBN 0 262 19407 4 , 1999, Trends in Neurosciences.
[98] R. Gillies,et al. Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin Receptors , 2008, International Journal of Peptide Research and Therapeutics.
[99] Eun Kyoung Ryu,et al. 18F-Labeled BBN-RGD Heterodimer for Prostate Cancer Imaging , 2008, Journal of Nuclear Medicine.
[100] K. Brown,et al. Combinatorial peptide libraries: mining for cell-binding peptides. , 2014, Chemical reviews.
[101] M. de Jong,et al. Radiopeptides for Imaging and Therapy: A Radiant Future , 2015, The Journal of Nuclear Medicine.
[102] Rhona A. Berganos,et al. Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels. , 2011, Radiology.
[103] M. Schwaiger,et al. [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. , 2004, Bioconjugate chemistry.
[104] U. Haberkorn,et al. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[105] M. Sailer,et al. Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA–substance P—results from a phase I study , 2010, Journal of Neuro-Oncology.
[106] Fan Wang,et al. An update of radiolabeled bombesin analogs for gastrin-releasing peptide receptor targeting. , 2013, Current pharmaceutical design.
[107] V. Kundra. Prostate cancer imaging. , 2006, Seminars in roentgenology.
[108] E. P. Krenning,et al. LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN , 1989, The Lancet.
[109] Matthew G. Vander Heiden,et al. Metabolic targets for cancer therapy , 2013, Nature Reviews Drug Discovery.
[110] R. Jensen,et al. Vasoactive Intestinal Peptide (VIP) and VIP Receptors-Elucidation of Structure and Function for Therapeutic Applications , 2011 .
[111] M. Bentley,et al. Chemistry for peptide and protein PEGylation. , 2002, Advanced drug delivery reviews.
[112] H. Kessler,et al. Ligands for Mapping a v 3 -Integrin Expression in Vivo , 2009 .
[113] Erkki Ruoslahti,et al. Anti-cancer activity of targeted pro-apoptotic peptides , 1999, Nature Medicine.
[114] C. Böttcher,et al. Switchable electrostatic interactions between gold nanoparticles and coiled coil peptides direct colloid assembly. , 2009, Organic & biomolecular chemistry.
[115] L. Wang,et al. Short chain bombesin pseudopeptides with potent bombesin receptor antagonist activity in rat and guinea pig pancreatic acinar cells. , 1990, European journal of pharmacology.
[116] Hua Wu,et al. Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3 , 2016, Theranostics.
[117] L. Andersson,et al. Large‐Scale Synthesis of Peptides , 2001 .
[118] M. Schwaiger,et al. PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[119] W. Oyen,et al. Radiolabelled peptides for oncological diagnosis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[120] A. Groves,et al. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐DPhe1,Tyr3‐octreotate) and 18F‐FDG , 2008, Cancer.
[121] Chenjie Xu,et al. PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles , 2008, Journal of Nuclear Medicine.
[122] K. Lee,et al. Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. , 1999, Biochemical pharmacology.
[123] E. Hostetler,et al. Biodistribution and Radiation Dosimetry of the Integrin Marker 18F-RGD-K5 Determined from Whole-Body PET/CT in Monkeys and Humans , 2012, The Journal of Nuclear Medicine.
[124] A. Wu,et al. Neuropeptide Y receptors: a promising target for cancer imaging and therapy , 2015, Regenerative biomaterials.
[125] Weibo Cai,et al. Positron emission tomography imaging using radiolabeled inorganic nanomaterials. , 2015, Accounts of chemical research.
[126] J. Bading,et al. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[127] Toshima Z. Parris,et al. Transcriptional response in normal mouse tissues after i.v. 211At administration - response related to absorbed dose, dose rate, and time , 2015, EJNMMI Research.
[128] K. Mukhopadhyay,et al. Alpha-Melanocyte Stimulating Hormone: An Emerging Anti-Inflammatory Antimicrobial Peptide , 2014, BioMed research international.
[129] Ido D. Weiss,et al. PET of Tumor CXCR4 Expression with 4-18F-T140 , 2010, The Journal of Nuclear Medicine.
[130] Dale O. Kiesewetter,et al. PET imaging of CXCR4 using copper-64 labeled peptide antagonist , 2011, Theranostics.
[131] V. Torchilin. Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.
[132] A. Groves,et al. A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors , 2008, Journal of Nuclear Medicine.
[133] M. Langer,et al. 99mTc-labeled neuropeptide Y analogues as potential tumor imaging agents. , 2001, Bioconjugate chemistry.
[134] J. Reubi,et al. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5 , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[135] R. Weissleder. Molecular Imaging in Cancer , 2006, Science.
[136] Tao Xi,et al. Studies of poly(ethylene glycol) modification of HM-3 polypeptides. , 2009, Bioconjugate chemistry.
[137] E. Hindié,et al. Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives with Bombesin, Neurotensin, and Neuropeptide-Y Receptors , 2014, The Journal of Nuclear Medicine.
[138] G. P. Smith,et al. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.
[139] Ashwani Kumar,et al. Bioactive peptides derived from milk proteins and their health beneficial potentials: an update. , 2011, Food & function.
[140] Xiaoyuan Chen,et al. Small-Animal PET of Tumors with 64Cu-Labeled RGD-Bombesin Heterodimer , 2009, Journal of Nuclear Medicine.
[141] Matthias Glaser,et al. Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand 18F-AH111585 in Breast Cancer Patients , 2008, Journal of Nuclear Medicine.
[142] Ick Chan Kwon,et al. Multifunctional nanoparticles for multimodal imaging and theragnosis. , 2012, Chemical Society reviews.
[143] Igor L. Medintz,et al. Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology. , 2013, Chemical reviews.
[144] J. Talbot,et al. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors. , 2011, Bioconjugate chemistry.
[145] O. Prante,et al. (18)F-glyco-RGD peptides for PET imaging of integrin expression: efficient radiosynthesis by click chemistry and modulation of biodistribution by glycosylation. , 2014, Molecular pharmaceutics.
[146] 松野 万希子. Role of acetylcholine and gastrin-releasing peptide (GRP) in gastrin secretion , 1998 .
[147] Peter S. Conti,et al. Pegylated Arg-Gly-Asp Peptide: 64Cu Labeling and PET Imaging of Brain Tumor αvβ3-Integrin Expression , 2004 .
[148] Erkki Ruoslahti,et al. Organ targeting In vivo using phage display peptide libraries , 1996, Nature.
[149] G. Liang,et al. Peptide-based nanostructures for cancer diagnosis and therapy. , 2014, Current medicinal chemistry.
[150] Christian Bruns,et al. Opportunities in somatostatin research: biological, chemical and therapeutic aspects , 2003, Nature Reviews Drug Discovery.
[151] W. Oyen,et al. Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting. , 2002, Cancer biotherapy & radiopharmaceuticals.
[152] R. Riek,et al. Ring size in octreotide amide modulates differently agonist versus antagonist binding affinity and selectivity. , 2008, Journal of medicinal chemistry.
[153] D. Cheng,et al. 18F-Radiolabeled GLP-1 analog exendin-4 for PET/CT imaging of insulinoma in small animals , 2013, Nuclear medicine communications.
[154] P. Espitia,et al. Bioactive Peptides: Synthesis, Properties, and Applications in the Packaging and Preservation of Food , 2012, Comprehensive reviews in food science and food safety.
[155] G. de Vincentis,et al. Gastrin-releasing peptide (GRP) analogues for cancer imaging. , 2004, Cancer biotherapy & radiopharmaceuticals.
[156] F. Kobarfard,et al. Synthesis and Preliminary Evaluation of a New 99mTc Labeled Substance P Analogue as a Potential Tumor Imaging Agent , 2015, Iranian journal of pharmaceutical research : IJPR.
[157] F Dumont,et al. Biodistribution and dosimetry of (99m)Tc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[158] H. Dai,et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. , 2020, Nature nanotechnology.
[159] Zeev Rosenzweig,et al. Synthesis and application of quantum dots FRET-based protease sensors. , 2006, Journal of the American Chemical Society.